USGL5DR: Ultrasound-guided L5 Dorsal Ramus Block

Sponsor
Montreal General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03805906
Collaborator
University of British Columbia (Other), Kelowna General Hospital (Other)
100
1
3.5
28.2

Study Details

Study Description

Brief Summary

This study will examine the accuracy of an ultrasound-guided L5 dorsal ramus block technique.

Condition or Disease Intervention/Treatment Phase
  • Procedure: L5 Dorsal ramus block

Detailed Description

The lumbar facet joints have been implicated as a causal factor in 15 to 40% of patients suffering from chronic low back pain. Because physical examination and medical imaging have limited value in determining the source of pain, diagnostic blocks play an important role in the management of this common condition. Blocks of the L5 dorsal ramus (DR) are used to diagnosed pain originating from the L5-S1 facet joint, which is one of the most commonly implicated levels in patients with low back pain. Fluoroscopic guidance, which uses x-rays, is currently the standard imaging modality used to perform this block. Recently, ultrasound guidance has seen increasing use because of its greater accessibility and lack of ionizing radiation. Although USG has been shown to provide a high level of accuracy at other levels, the greater anatomical complexity found at the L5-S1 has hindered the development of a satisfactory L5 DR block technique. In this study the investigators will use fluoroscopic control to examine the accuracy of a novel ultrasound-guided approach to this block.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Ultrasound-guided L5 Dorsal Ramus Block: Description and Validation of a Novel Technique
Actual Study Start Date :
Jan 12, 2019
Actual Primary Completion Date :
Apr 30, 2019
Actual Study Completion Date :
Apr 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Primary group

Ultrasound-Guided L5 Dorsal ramus block

Procedure: L5 Dorsal ramus block
Ultrasound-guided L5 dorsal ramus block

Outcome Measures

Primary Outcome Measures

  1. Block accuracy [Immediately post-injection]

    contrast distribution

Secondary Outcome Measures

  1. Performance time [Perioperative]

    Performance time as defined by the time the first image is acquired until the time the contrast injection is completed.

  2. Number of needle passes [Procedure]

    Number of needle passes required to perform block

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

-Any consenting patient over 18 years of age with axial low back pain who requires a diagnostic L5 dorsal ramus block.

Exclusion Criteria:
  • Inability to consent

  • Iodine or lidocaine allergy,

  • Pregnancy,

  • Coagulopathy (as defined by an INR over 1.4, platelets under 100,000, or a documented bleeding disorder)

  • Inability to visualize lumbosacral anatomy during an ultrasound pre- scan

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kelowna General Hospital Kelowna British Columbia Canada V1Y 1T2

Sponsors and Collaborators

  • Montreal General Hospital
  • University of British Columbia
  • Kelowna General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roderick Finlayson, Professor, Montreal General Hospital
ClinicalTrials.gov Identifier:
NCT03805906
Other Study ID Numbers:
  • 2018-19-061-H
First Posted:
Jan 16, 2019
Last Update Posted:
Sep 16, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2020